AI is driving exciting breakthroughs across the pharmaceutical value chain, especially in early-stage drug discovery, Jayson Lee, partner at LongRiver Investments, said at the International Biopharma Industry Week Shanghai. The real innovation does not lie in shining light where we already know but in venturing into uncharted territory at the very source of medicine, he added. #IBIWS2026